Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Johnson & Johnson
(NY:
JNJ
)
149.27
-0.65 (-0.43%)
Official Closing Price
Updated: 7:00 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Johnson & Johnson
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Johnson & Johnson (NYSE: JNJ) is One of Monday Morning’s Most Active Stocks
August 21, 2023
Via
Investor Brand Network
Johnson & Johnson Announces Preliminary Results of Kenvue Inc. Exchange Offer
August 21, 2023
From
Johnson & Johnson
Via
Business Wire
Antiepileptic Drugs Market to Witness Massive Growth by 2028 : Johnson & Johnson, Sumitomo Pharma, Sanofi
August 17, 2023
Stay up to date with Antiepileptic Drugs Market research offered by HTF MI. Check how key trends and emerging drivers are shaping this industry growth.
Via
SBWire
Johnson & Johnson Announces Final Exchange Ratio of 8.0324 in Split-Off of Kenvue Inc.
August 16, 2023
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson (NYSE: JNJ) Near Top of Volume Charts in Tuesday Trading
August 15, 2023
Via
Investor Brand Network
Johnson & Johnson (NYSE: JNJ) Highlighted for Surprising Price Action
July 20, 2023
Via
Investor Brand Network
5 Best Stocks to Buy in a Bear Market
August 11, 2023
Want income-producing assets and stable stocks? Look for stocks with stable cash flow in rock-solid industries for the best stocks to buy in a bear market.
Via
MarketBeat
Topics
Economy
Exposures
Economy
3 Stocks to Play the Recovery in Digital Advertising
August 08, 2023
The slowdown in digital advertising triggered many technology stocks to sell off, notably social media platforms like Snap Inc. (NASDAQ: SNAP). However, a
Via
MarketBeat
Topics
Earnings
Exposures
Financial
Johnson & Johnson to Participate in the 2023 Wells Fargo Securities Healthcare Conference
August 07, 2023
From
Johnson & Johnson
Via
Business Wire
Rising Dividend Make Zoetis a Doggone Winner
August 03, 2023
Investors that typically focus on other large cap pharmaceutical plays may wish to consider an alternative bet on pets with shares of Zoetis.
Via
MarketBeat
Nachawati Law Group Trial Lawyers Renew Commitment to Cancer Victims After Judge’s Rejection of Johnson & Johnson’s Proposed $8.9B Settlement
July 31, 2023
From
Nachawati Law Group
Via
Business Wire
3 Consumer Discretionary Stocks That Still Have Pricing Power
July 24, 2023
Pricing power fuels earnings growth and here are three consumer discretionary stocks that have recently given investors confirmation of their pricing power
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
Kenvue To File Form S-4 Registration Statement in Connection with Johnson & Johnson Exchange Offer Announcement
July 24, 2023
From
Kenvue Inc.
Via
Business Wire
Johnson & Johnson Launches Exchange Offer for Separation of Kenvue Inc.
July 24, 2023
From
Johnson & Johnson
Via
Business Wire
MarketBeat Week in Review – 7/17 - 7/21
July 22, 2023
Investor sentiment remains strong but upcoming tech earnings and an expected interest rate hike may provide more clarity on the short-term outlook for stocks
Via
MarketBeat
Topics
Economy
Exposures
Economy
Interest Rates
Johnson & Johnson's Inflection Point: What it Means for Investors
July 20, 2023
Johnson & Johnson stock and the company show signs of strength and growth while offering value and yield relative to its peer Abbott Laboratories.
Via
MarketBeat
Exposures
COVID-19
Johnson & Johnson Reports Q2 2023 Results
July 20, 2023
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson to Participate in the UBS MedTech, Tools and Genomics Summit
July 10, 2023
From
Johnson & Johnson
Via
Business Wire
Inspire Medical Up 15% After Breakout, Analysts Say It's A Buy
July 06, 2023
Inspire Medical Systems has surged nearly 15% since its breakout, driven by positive Q1 results and FDA approvals. Analysts have a "buy" rating on the stock.
Via
MarketBeat
Exposures
Product Safety
OnderLaw Lauds Revolutionary Drug Combination that Offers Hope for Women with Ovarian Cancer
June 23, 2023
June 23, 2023 -- Drug Combination Shows Special Promise to Those Diagnosed with Johnson & Johnson Talc-Related Ovarian Cancer
Via
24-7 Press Release
Red Hot Eli Lilly Rolls the DICE With Its Latest Biotech Takeover
June 21, 2023
The market’s initial positive reaction to the DICE Therapeutics news suggests Eli Lilly shares will continue to sizzle this summer.
Via
MarketBeat
Will Cava's Successful Debut Raise Hope For Reviving IPO Market?
June 21, 2023
Cava's strong IPO performance suggests a warming trend in the market for new public debuts. However, several eagerly anticipated offerings remain on hold.
Via
MarketBeat
Topics
Initial Public Offering
Exposures
Securities Market
Filariasis Market and Epidemiology 2032: Treatment Market, Therapies, FDA Approvals, and Companies by DelveInsight | Johnson & Johnson, Pfizer, Eisai Co Ltd, Atra Pharmaceuticals, AbbVie, Novartis
June 14, 2023
Via
AB Newswire
Exposures
Product Safety
Ophthalmoplegia Market expected to rise | Companies – Abbott, Novartis AG, ZEISS International, Valeant Pharmaceuticals International, ALLERGAN, Johnson & Johnson, expected to drive market
June 13, 2023
Via
AB Newswire
2022 R&D Spending and Intensity Benchmarks
June 12, 2023
VIRGINIA BEACH, Va. - June 12, 2023 - PRLog -- According to a newly released study from Schonfeld & Associates, Inc., R&D Ratios & Budgets, the pharmaceutical industry continued to be the biggest R&D...
Via
PRLog
Topics
Supply Chain
Exposures
Supply Chain
Alvotech and Teva Secure U.S. License Date for AVT04, a Proposed Biosimilar to Stelara®
June 12, 2023
From
Alvotech
Via
GlobeNewswire
Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results
June 06, 2023
From
Johnson & Johnson
Via
Business Wire
Smokeless Tobacco Treatment Market to See Booming Growth : Novartis, Pfizer, Johnson & Johnson, Cambrex
May 26, 2023
Smokeless Tobacco Treatment Comprehensive Study by Type (Keratosis Treatment, Addiction Treatment, Disease Treatment), Application (Hospitals & Clinics, Academic & Research Organizations, Pharmacies),...
Via
SBWire
Exposures
Climate
Will Dividends Take Center Stage In The Second Half Of 2023?
May 23, 2023
The NYSE Composite's sideways trade since early 2021 could be a warning sign, suggesting that a shift toward dividend strategies may be prudent.
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Tampons Market Is Booming Worldwide : Johnson & Johnson, Kimberly-Clark, Ontex, Unicharm
May 18, 2023
Tampons Comprehensive Study by Type (Radially Wound Pledget, Rectangular/Square Pad), Distribution Channel (Online, Offline (Supermarkets/Hypermarkets, Independent Retailers, Specialty Stores, Drug...
Via
SBWire
Exposures
Textiles
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.